相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Rajeev Gautam et al.
NATURE (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Till Schoofs et al.
SCIENCE (2016)
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu et al.
SCIENCE (2016)
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
David J. DiLillo et al.
CELL (2015)
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Taia T. Wang et al.
CELL (2015)
The role of Fc-FcγR interactions in IgG-mediated microbial neutralization
Stylianos Bournazos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs
Benjamin M. Fiebiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI
Masato Kiyoshi et al.
NATURE COMMUNICATIONS (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
Alysia A. Ahmed et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic et al.
NATURE IMMUNOLOGY (2014)
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants
Shigemi Yoshihara et al.
PEDIATRICS (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
General mechanism for modulating immunoglobulin effector function
Peter Sondermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
Xiangguo Qiu et al.
SCIENTIFIC REPORTS (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
Inessa Schwab et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein et al.
NATURE (2012)
A mouse model for HIV-1 entry
John Pietzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Autonomous phagosomal degradation and antigen presentation in dendritic cells
Eik Hoffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Patrick Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcεRI
Balvinder Dhaliwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Platelet-leukocyte interactions in thrombosis
Chiara Cerletti et al.
THROMBOSIS RESEARCH (2012)
Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults
Nithya Gogtay et al.
VACCINE (2012)
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
K. Tamura et al.
ANNALS OF ONCOLOGY (2011)
Basis of the Intrinsic Flexibility of the Cε3 Domain of IgE
Susmita Borthakur et al.
BIOCHEMISTRY (2011)
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Robert M. Anthony et al.
NATURE (2011)
Analysis of the antibody structure based on high-resolution crystallographic studies
Jo Erika T. Narciso et al.
NEW BIOTECHNOLOGY (2011)
IgE-Mediated Enhancement of CD4+ T Cell Responses in Mice Requires Antigen Presentation by CD11c+ Cells and Not by B Cells
Frida Henningsson et al.
PLOS ONE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
Cherie T. Ng et al.
NATURE MEDICINE (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Functional and clinical consequences of Fc receptor polymorphic and copy number variants
S. Bournazos et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
Frederic Bibeau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Raxibacumab for the Treatment of Inhalational Anthrax.
Thi-Sau Migone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
Bjoern Tackenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Distinct cell-specific control of autoimmunity and infection by FcγRIIb
Rebecca J. Brownlie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
Heike Albert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification of a receptor required for the anti-inflammatory activity of IVIG
Robert M. Anthony et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
FCGR2A and FCGR3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program
Kavita M. Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fcγ receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses
Dharmesh D. Desai et al.
JOURNAL OF IMMUNOLOGY (2007)
Fc gamma RIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang et al.
NATURE IMMUNOLOGY (2007)
Fc gamma receptors: Old friends and new family members
F Nimmerjahn et al.
IMMUNITY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells
A Bergtold et al.
IMMUNITY (2005)
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
AM Boruchov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
RA Floto et al.
NATURE MEDICINE (2005)
Decreased transcription of the human FCGR2B gene mediated by the-343 G/C promoter polymorphism and association with systemic lupus erythematosus
MC Blank et al.
HUMAN GENETICS (2005)
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
KM Dhodapkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis
MR Clatworthy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Passive antibody therapy for infectious diseases
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2004)
The coordination of signaling during Fc receptor-mediated phagocytosis
JA Swanson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity.: I.: Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus
KH Su et al.
JOURNAL OF IMMUNOLOGY (2004)
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies
NL Haigwood et al.
JOURNAL OF VIROLOGY (2004)
Genomic organization of classical human low-affinity Fcγ receptor genes
K Su et al.
GENES AND IMMUNITY (2002)
Involvement of GD3 in platelet activation. A novel association with Fcgamma receptor
F Martini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells
AM Kalergis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Genetic modifiers of systemic lupus erythematosus in FcγRIIB-/- mice
S Bolland et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
IgG2a-mediated enhancement of antibody responses is dependent on FcRγ+ bone marrow-derived cells
TD De Ståhl et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Molecular basis for immune complex recognition: A comparison of Fc-receptor structures
P Sondermann et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
S Bolland et al.
IMMUNITY (2000)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
分享论文
